Gildan Activewear's Shares Plunge 18% Following Forensic Investigation Revelations

Turbulent Times for Gildan Activewear: Share Price Dives 18%

On June 16, 2026, shares of Gildan Activewear Inc. (NYSE: GIL) plummeted by over 18%, resulting in a staggering loss of approximately $2.15 billion from the company’s market capitalization. This dramatic drop was triggered by a scathing forensic report released by Jehoshaphat Research that accused Gildan of engaging in potentially improper sales practices, namely channel stuffing and questionable revenue recognition.

The Forensic Report's Claims

Jehoshaphat Research's report, titled "STUFFING ALL OF THE CHANNEL SOME OF THE TIME?", raised serious concerns about Gildan's business operations. The firm claimed to have gathered substantial evidence from interviews with former employees, customers, and distributors that supported their accusations against Gildan. The allegations detailed that Gildan had been pressuring its customers to pull forward orders close to quarter-end, using incentives such as extreme payment terms.

One highlighted practice involved Gildan providing products to distributors and customers but not requiring payment until after the items had been resold. According to Jehoshaphat’s findings, this practice was employed as a strategy to artificially inflate sales figures to meet market expectations.

Advocacy and Investigations

Following the revelations, the national shareholder rights firm, Hagens Berman, announced an investigation into the validity of these allegations and whether Gildan’s actions constituted a breach of federal securities laws. Hagens Berman is inviting investors who purchased Gildan shares and incurred significant losses to come forward. The firm is also reaching out to anyone possessing knowledge of Gildan's sales practices to assist in their inquiry.

Reed Kathrein, a partner at Hagens Berman, emphasized the importance of determining whether Gildan's reported practices were indeed inaccurate, saying, "Our investigation is focused on whether Jehoshaphat's analyses are correct, and if so, whether Gildan has engaged in improper revenue recognition practices."

Gildan’s Assurance to Investors

In light of these allegations, Gildan has previously assured its investors that its financial statements are prepared in accordance with all applicable accounting standards, including those regulating proper revenue recognition. However, the questions arising from the forensic report have put that assurance into doubt.

Jehoshaphat’s investigation revealed that Gildan's sales strategy involved incentivizing distributors to buy more inventory than usual, especially if it seemed that the quarterly sales targets might not be met. For instance, sales staff were known to offer rebates and favorable payment terms to facilitate this conduct.

Current Investor Sentiment

The decline in Gildan's market value has clearly unsettled investors, igniting concerns over the firm’s future viability and compliance with financial regulations. With the market's reaction to the report, many are left questioning the trustworthiness of Gildan's previous assurances regarding its financial health and sales methods.

Investors affected by the stock drop are encouraged to monitor developments in the ongoing investigation, as any findings by Hagens Berman may directly impact their ownership stakes in the company. Moreover, whistleblowers with non-public information regarding Gildan’s operational practices might also wish to consider their options under the SEC Whistleblower program, which offers rewards for information that aids in significant recoveries.

Gildan's Future: What Lies Ahead?

While Gildan strives to dismiss these allegations, the shadow of doubt cast by the forensic report might continue to haunt the corporate giant. As the situation unfolds, Gildan's transparency and adherence to ethical practices will be critical in restoring investor confidence and navigating the turbulent waters ahead. The results of Hagens Berman’s investigation will be closely watched, as they could lead to significant changes in Gildan’s operational or financial practices moving forward.

In conclusion, the recent scrutiny on Gildan Activewear is a cautionary tale for investors in the activewear sector, highlighting the importance of rigorous due diligence and the potential ramifications of corporate misconduct.